Dead tumor cells expressing infectious salmon anemia virus fusogenic protein favor antigen cross-priming in vitro
Artículo
Open/ Download
Date
2017Metadata
Show full item record
Cómo citar
Morales, Jonathan
Cómo citar
Dead tumor cells expressing infectious salmon anemia virus fusogenic protein favor antigen cross-priming in vitro
Author
- Morales, Jonathan;
- Barrera Avalos, Carlos;
- Castro, Carlos;
- Castillo, Stephanie;
- Barrientos, Claudio;
- Robles Planells, Claudia;
- López, Ximena;
- Torres, Ernesto;
- Montoya, Margarita;
- Cortez San Martin, Marcelo;
- Riquelme, Denise;
- Escobar Álvarez, Alejandro;
- Fernández, Ricardo;
- Imarai, Mónica;
- Sauma Mahaluf, Daniela;
- Rojo, Leonel E.;
- Leiva Salcedo, Elias;
- Acuña Castillo, Claudio;
Abstract
Antigen cross-presentation is a crucial step in the assembly of an antitumor immune response leading to activation of naive CD8 T cells. This process has been extensively used in clinical trials, in which dendritic cells generated in vitro are loaded with tumor antigens and then autotransplanted to the patients. Recently, the use of autologous transplant of dendritic cells fused with dying tumor cells has demonstrated good results in clinical studies. In this work, we generated a similar process in vivo by treating mice with dead tumor cells [cell bodies (CBs)] expressing the fusogenic protein of the infectious salmon anemia virus (ISAV). ISAV fusion protein retains its fusogenic capability when is expressed on mammalian cells in vitro and the CBs expressing it facilitates DCs maturation, antigen transfer by antigen-presenting cells, and increase cross-presentation by DCs in vitro. Additionally, we observed in the melanoma model that CBs with or without ISAV fusion protein reduce tumor growth in prophylactic treatment; however, only ISAV expressing CBs showed an increase CD4 and CD8 cells in spleen. Overall, our results suggest that CBs could be used as a complement with other type of strategies to amplify antitumor immune response.
Patrocinador
FONDECYT
1110734
1161015
11140915
11140731
PAI
79140059
DICYT
DGT s/n
CONICYT
Indexation
Artículo de publicación ISI
Quote Item
Front. Immunol. 8:1170
Collections
The following license files are associated with this item: